{"title":"RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation","authors":"","doi":"10.1111/cas.16312","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: C.-W. Li, J. Zheng, G.-Q. Deng, Y.-G. Zhang, Y. Du and H.-Y. Jiang, “Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation,” <i>Cancer Science</i> 113, no. 5 (2022): 1652–1668, https://doi.org/10.1111/cas.15337.</p><p>The above article, published online on 16 March 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that images of pathological results were duplicated across other articles in a different scientific context. The authors acknowledge the duplication of the images and apologise for the errors. Despite the authors providing all original data and reconducting the animal pathology experiments, given the extent and nature of duplications found, the editors consider the results and conclusion of this article to be invalid.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"115 11","pages":"3829"},"PeriodicalIF":4.5000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531962/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16312","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
RETRACTION: C.-W. Li, J. Zheng, G.-Q. Deng, Y.-G. Zhang, Y. Du and H.-Y. Jiang, “Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation,” Cancer Science 113, no. 5 (2022): 1652–1668, https://doi.org/10.1111/cas.15337.
The above article, published online on 16 March 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that images of pathological results were duplicated across other articles in a different scientific context. The authors acknowledge the duplication of the images and apologise for the errors. Despite the authors providing all original data and reconducting the animal pathology experiments, given the extent and nature of duplications found, the editors consider the results and conclusion of this article to be invalid.
撤回:C.-W. Li, J. Zheng, G.-Q.Li, J. Zheng, G.-Q.Deng, Y.-G. Zhang, Y. Du and H.-Y.Zhang, Y. Du and H.-Y. Jiang, "Exosomal miR-106a-5p Accelerer the Progression of Nasasics.Jiang, "Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation," Cancer Science 113, no.5 (2022): 1652-1668, https://doi.org/10.1111/cas.15337。上述文章于 2022 年 3 月 16 日在线发表于 Wiley Online Library (wileyonlinelibrary.com),经作者、杂志主编 Masanori Hatakeyama、日本癌症协会和 John Wiley & Sons Australia, Ltd.(澳大利亚约翰威利父子有限公司)协商,已被撤回。在对第三方提出的疑虑进行调查后,作者同意撤稿。调查显示,病理结果的图片在不同科学背景下的其他文章中被重复引用。作者承认复制了图片,并对错误表示歉意。尽管作者提供了所有原始数据并重新进行了动物病理学实验,但鉴于发现的重复程度和性质,编辑认为这篇文章的结果和结论无效。
期刊介绍:
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.
Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.